"Dr Leo Galland--you can read--he got a Linus Pauling award. Graduated Harvard.Thats impressive. He uses TolloVID to fight viral replication--even has a guidebook for Long Covid" Quote TSM
Tollovid from Todos Medical, 3 capsules 4 times a day for 10-15 days. The active ingredient is a Chinese herbal product called red gromwell root (Lithospermiumerythrorhizon), which has a very high safety profile and has been used in Chinese medicine for a thousand years. Its main mode of action is to inhibit a key viral enzyme called the main protease, which is also the target of the anti-viral drug Paxlovid (more about the coronavirus main protease in APPENDIX D, Coronavir PART 2. After Entry : the Role of NSP’s (non structural proteins) Once inside your cells, the corona virus takes over the normal cellular machinery to replicate itself. Its first act is to create a large complex poly-protein that rapidly splits itself into 16 smaller structures called non-structural proteins (nsp’s) that function to evade your immune system, punch holes in your cells and enable the production of structural proteins. One of these, nsp-5, also known as the main protease or 3CL-protease, is essential for viral spreading because it acts like a scissor to break out 12 of the other nsp’s. It works in tandem with nsp-3, also called papain-line protease, which releases two other segments of the polyprotein. Because 3-CL protease is so essential for viral growth, it’s been called the “Achilles heel” of the corona virus family. In the laboratory, inhibition of 3CL-protease can totally block replication of SARS-CoV-2. Natural inhibitors are already known . They include: • Shikonin, extracted from the Chinese and Korean herb Lithospermium erythrorhizon (red gromwell root) https://drgalland.com/wp-content/uploads/2023/01/LONG-COVID-PREVENTION-AND-TREATMENT-FINAL1.pdf
"And also Dr Hanaway--he gives info in a podcast. But there is a transcript if needed??."Quote TSM
first working with this 3CL protease inhibitor, Tollovid, developed out of Israel and something that we looked at and we said, “Well, can we use some other antiviral? Would that work?” But we continue to find in our beta testing that this is a critical tool for people, and it seems to be acting in twofold. One, around those where there is a viral persistence, but it also seems to be helping with the viral reactivation of the herpetic viruses like Epstein Barr. People are feeling better with it. And if you had COVID for less than a year, we give it for 10 days. If you had it for more than a year, we’re giving it for 20 days. https://www.drkarafitzgerald.com/2023/04/15/addressing-long-covid-data-driven-learning-model-for-practitioners-and-patients/
News 
Market Data 
Discover 
